Replicative in vivo gene targeting
CA 2437790 C · Owner: Lydiate, Derek J. · Inventors: Lydiate, Derek J.; Rozwadowski, Kevin L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
In some embodiments, the invention provides gene targeting systems that renew or regenerate a gene targeting cassette by various mechanisms of DNA replication to enable repeated cycles of gene targeting substrate production in vivo. In some embodiments, successive rounds of gene targeting cassette replication may allow the accumulation of multiple molecules of gene targeting substrate per cell or nucleus, so that the presence of more gene targeting substrate may result in a higher frequency of gene targeting events to produce heritable changes in a target host sequence by processes such as nucleic acid recombination and/or repair.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 7, 2002 and granted April 15, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 7, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 7, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.